Association between the antibiotics use and recurrence in patients with resected colorectal cancer: EVADER-1, a nation-wide pharmaco-epidemiologic study
Digestive and Liver Disease · 2025
DOI: 10.1016/j.dld.2024.07.030 ↗Kurz gefasst
Fachartikel in der Zeitschrift Digestive and Liver Disease, 2025. Verfasst von Marc Hilmi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Institut Curie, Versailles Saint-Quentin University, Saint-Cloud, France; GERCOR, Paris, France. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Neoplasm Recurrence, Local, Anti-Bacterial Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: National Cancer Institute.
Abstract (Originalsprache)
BACKGROUND: The impact of antibiotics (ATBs) on the risk of colorectal cancer (CRC) recurrence after curative resection remains unknown. METHODS: Using the French nation-wide database of cancer patients, all newly diagnosed non-metastatic CRC patients resected between 01/2012 and 12/2014 were included. The perioperative ATB intake (from 6 months before surgery until 1 year after) was classified according to the class, the period of use (pre- vs post-resection), the disease stage (localized and locally advanced), and the primary tumor location (colon and rectum/junction). The primary endpoint was the 3-year disease-free survival (DFS). The impact of ATB was assessed using time-dependent multivariate Cox models. RESULTS: A total of 35,496 CRC patients were included. Seventy-nine percent of patients had at least one ATB intake. Outpatient ATB intake after surgery was associated with unfavorable 3-year DFS. The ATBs associated with decreased 3-year DFS were cephalosporins, streptogramins, quinolones, penicillin A with beta-lactamase inhibitors, and antifungals with differential effects according to the primary tumor location and disease stage. CONCLUSION: These findings suggest that ATBs modulate the risk of recurrence after early CRC resection with a differential impact of the ATB classes depending on disease stage and tumor site.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Institut Curie, Versailles Saint-Quentin University, Saint-Cloud, France; GERCOR, Paris, France.
- Department of Health Data and Assessment, Health Survey, Data-science and Assessment Division, French National Cancer Institute (INCa), Boulogne Billancourt, France.
- GERCOR, Paris, France; Department of Medical Oncology, Lille University Hospital, Lille, France.
- INSERM IAME UMR 1137, Paris, France.
- Department of Epidemiology, Biostatistics and Clinical Research, Bichat Hospital, AP-HP, Paris, France.
- Microbiology Laboratory, Bichat-Claude Bernard University Hospital, AP-HP, Paris, France.
Förderung
- National Cancer Institute
Zitieren
APA
Hilmi, M., Khati, I., Turpin, A., Andremont, A., Burdet, C., Grall, N., Vidal, J., Bousquet, P. J., Rousseau, B., & Bihan-Benjamin, C. L. (2025). Association between the antibiotics use and recurrence in patients with resected colorectal cancer: EVADER-1, a nation-wide pharmaco-epidemiologic study. Digestive and Liver Disease. https://doi.org/10.1016/j.dld.2024.07.030
Vancouver
Hilmi M, Khati I, Turpin A, Andremont A, Burdet C, Grall N, et al. Association between the antibiotics use and recurrence in patients with resected colorectal cancer: EVADER-1, a nation-wide pharmaco-epidemiologic study. Digestive and Liver Disease. 2025. doi:10.1016/j.dld.2024.07.030
BibTeX
@article{Hilmi2025,
author = {Hilmi, Marc and Khati, Ines and Turpin, Anthony and Andremont, Antoine and Burdet, Charles and Grall, Nathalie and Vidal, Joana and Bousquet, Philippe-Jean and Rousseau, Benoît and Bihan-Benjamin, Christine Le},
title = {Association between the antibiotics use and recurrence in patients with resected colorectal cancer: EVADER-1, a nation-wide pharmaco-epidemiologic study},
journal = {Digestive and Liver Disease},
year = {2025},
doi = {10.1016/j.dld.2024.07.030}
}
EUVIMED